Abstract: An automated molecular operating system includes at least one centrifuge tube carrying module, a transport module, a plurality of temperature control modules, a capping module, a magnetic field module and an automated processing module. The automated processing module is electrically connected to the transport module, the temperature control modules, the capping module and the magnetic field module, and controls the transport module to move the centrifuge tube carrying module, so that a centrifuge tube contained in the centrifuge tube carrying module makes a reaction in the temperature control modules, and the magnetic field module or the capping module is provided to the centrifuge tube according to requirements, such that a specimen in the centrifuge tube can be automatically subjected to nucleic acid extraction, nucleic acid amplification, primer labeling, reverse transcription or a combination thereof, thereby reducing manual operation errors and increasing the ease of operation.

Abstract: The invention provides a layout pattern of static random access memory (SRAM), which at least comprises a plurality of gate structures located on a substrate and spanning the plurality of fin structures to form a plurality of transistors distributed on the substrate, wherein the plurality of transistors comprise two pull-up transistors (PU), two pull-down transistors (PD) to form a latch circuit, and two access transistors (PG) connected to the latch circuit. In each SRAM memory cell, the fin structure included in the pull-up transistor (PU) is defined as a PU fin structure, the fin structure included in the pull-down transistor (PD) is defined as a PD fin structure, and the fin structure included in the access transistor (PG) is defined as a PG fin structure, wherein a width of the PD fin structure is wider than a width of the PG fin structure.

Abstract: The present disclosure provides a use of a pharmaceutical composition including adenine and/or a pharmaceutically acceptable salt thereof in a manufacture of a medicament for treating diabetic ulcers, and the medicament can effectively accelerate and enhance wound healing of diabetic ulcers and prevent scar formation.

Abstract: The present invention relates to adenine which is useful to activate AMP-activated protein kinase (AMPK) and the use of adenine in the prevention or treatment of conditions or disease and thereby prevent or treat conditions or diseases which can be ameliorated by AMPK in a mammal.

Abstract: The present invention relates to adenine which is useful to activate AMP-activated protein kinase (AMPK) and the use of adenine in the prevention or treatment of conditions or disease and thereby prevent or treat conditions or diseases which can be ameliorated by AMPK in a mammal.

Abstract: Provided is a composition for wound healing, which includes adenine and a pharmaceutically acceptable salt thereof. Also provided is a method for enhancing wound healing in a subject in need thereof including administering to the subject the composition.

Abstract: A method for determining credibility of content in a number of documents includes: obtaining topics from each document; for each document, generating topic combinations, each topic combination being a subset of the topics of the document; for each topic combination, obtaining a summary from the corresponding document; performing a semantic similarity test on each pair of two summaries that are respectively from two documents, so as to obtain a similarity percentage between the two summaries; for a group of the topic combinations that are identical combinations of topic(s), calculating a credibility score for the group based on the similarity percentage(s) calculated for the summaries that correspond to the topic combinations in the group.

Abstract: Provided is a composition for wound healing, which includes adenine and a pharmaceutically acceptable salt thereof. Also provided is a method for enhancing wound healing in a subject in need thereof including administering to the subject the composition.

Abstract: Provided is a composition for wound healing, which includes adenine and a pharmaceutically acceptable salt thereof. Also provided is a method for enhancing wound healing in a subject in need thereof including administering to the subject the composition.

Abstract: The present invention relates to adenine which is useful to activate AMP-activated protein kinase (AMPK) and the use of adenine in the prevention or treatment of conditions or disease and thereby prevent or treat conditions or diseases which can be ameliorated by AMPK in a mammal.

Abstract: The present invention relates to adenine which is useful to activate AMP-activated protein kinase (AMPK) and the use of adenine in the prevention or treatment of conditions or disease and thereby prevent or treat conditions or diseases which can be ameliorated by AMPK in a mammal.

Abstract: The present invention relates to adenine which is useful to activate AMP-activated protein kinase (AMPK) and the use of adenine in the prevention or treatment of conditions or disease and thereby prevent or treat conditions or diseases which can be ameliorated by AMPK in a mammal.

Abstract: The present invention relates to adenine which is useful to activate AMP-activated protein kinase (AMPK) and the use of adenine in the prevention or treatment of conditions or disease and thereby prevent or treat conditions or diseases which can be ameliorated by AMPK in a mammal.

Abstract: A system for extending life expectancy of disks in a cloud-based service system and the system using the method are disclosed. The present invention uses LSTM modeling and the k-means clustering algorithms to find out performance limit and target lifespan for a cluster of disks assigned for a specific workload running over the cloud-based service system. The disks can be predicted to have a minimum lifetime and the requirement of the workload can be satisfied. Meanwhile, the minimum lifetime is the longest life the disk can last.

Abstract: A method for data protection in a cloud-based service system is disclosed. The method includes the steps of: A. collecting historical operating data of storage devices in the cloud-based service system; B. building up a life expectancy model and a next-7-days failure probability model by the collected operating data; C. inputting operating data in the past 24-hours into the life expectancy model and the next-7-days failure probability model for every storage device to obtain ranges of expected lifespans in respective groups and corresponding failure probabilities; and D. backing up data in the storage devices according to the results of step C.

Abstract: Provided is a composition for wound healing, which includes adenine and a pharmaceutically acceptable salt thereof. Also provided is a method for enhancing wound healing in a subject in need thereof including administering to the subject the composition.

Abstract: A method for optimizing storage configuration for future demand and a system applying the method are disclosed. The system includes a monitoring module, a storage recording module, a traffic modeling module, a rule-based decision module, and a storage management module. With performance values and utilization values provided from the monitoring module, a traffic status of data access in a particular time in the future can be generated. Then, a storage configuration with the workload requirement according to some rules can be available. The storage configuration is implemented to fulfill the requirement of the traffic status of data access.

Abstract: A system for extending life expectancy of disks in a cloud-based service system and the system using the method are disclosed. The present invention uses LSTM modeling and the k-means clustering algorithms to find out performance limit and target lifespan for a cluster of disks assigned for a specific workload running over the cloud-based service system. The disks can be predicted to have a minimum lifetime and the requirement of the workload can be satisfied. Meanwhile, the minimum lifetime is the longest life the disk can last.

Abstract: The present invention relates to a method for treating disease or condition susceptible to amelioration by AMPK activators and compounds of formula which are useful to activate AMP-activated protein kinase (AMPK) and the use of the compounds in the prevention or treatment of disease, including pre-diabetes, type 2 diabetes, syndrome X, metabolic syndrome and obesity.

Abstract: A method and system for storage traffic modeling in a Software Defined Storage (SDS) is disclosed. The method includes the steps of: collecting observed values of at least one performance parameter in a period of time from a storage node; learning a trend structure of the at least one performance parameter varying with time from the observed values; and providing a predicted value of one performance parameter in a particular point in time in the future. The storage node is operated by SDS software. The trend structure is adjusted based on observed values collected after the period of time. The predicted value is an output of the trend structure which has been adjusted.